Up-regulation of endothelial nitric oxide synthase through β2-adrenergic receptor -: The role of a β-blocker with NO-releasing action

被引:22
作者
Jayachandran, M
Hayashi, T
Sumi, D
Thakur, NK
Kano, H
Ignarro, LJ
Iguchi, A
机构
[1] Nagoya Univ, Grad Sch Med, Dept Geriatr, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
关键词
endothelial nitric oxide synthase; caveolin-1; beta(2)-adrenergic receptor antagonist; nitric oxide;
D O I
10.1006/bbrc.2000.4177
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We determined the existence and role of beta (2)-adrenergic receptor in cultured BAECs through the effect of a beta -blocker having NO releasing action; 3,4-dihydro-8 (2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran; nipradilol on eNOS and eNOS regulatory protein caveolin-1. beta (2) receptor exists in BAECs. eNOS mRNA and protein were up-regulated by its treatment whereas those of caveolin were not altered considerably. This eNOS up-regulatory action was abolished by beta (2) receptor antagonist, ICI-118551. Increase of NO metabolites, protein and mRNA of eNOS was also partially inhibited by co-treatment of NOS inhibitor, L-NA with nipradilol. This is the first investigation of the action of non-selective beta blocker on eNOS through beta (2) receptor. The drug increases NO on incubation with BAECs about 50% as a NO donor and about 50% as results of eNOS up-regulation. (C) 2001 Academic Press.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 22 条
[1]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[2]   Endothelial nitric oxide synthase targeting to caveolae - Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells [J].
Feron, O ;
Belhassen, L ;
Kobzik, L ;
Smith, TW ;
Kelly, RA ;
Michel, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22810-22814
[3]   CALMODULIN-DEPENDENT ENDOTHELIUM-DERIVED RELAXING FACTOR NITRIC-OXIDE SYNTHASE ACTIVITY IS PRESENT IN THE PARTICULATE AND CYTOSOLIC FRACTIONS OF BOVINE AORTIC ENDOTHELIAL-CELLS [J].
FORSTERMANN, U ;
POLLOCK, JS ;
SCHMIDT, HHHW ;
HELLER, M ;
MURAD, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) :1788-1792
[4]   Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling [J].
GarciaCardena, G ;
Oh, P ;
Liu, JW ;
Schnitzer, JE ;
Sessa, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) :6448-6453
[5]   Dissecting the interaction between nitric oxide synthase (NOS) and caveolin - Functional significance of the NOS caveolin binding domain in vivo [J].
GarciaCardena, G ;
Martasek, P ;
Masters, BSS ;
Skidd, PM ;
Couet, J ;
Li, SW ;
Lisanti, MP ;
Sessa, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25437-25440
[6]   EFFECTS OF NICORANDIL AND NIPRADILOL ON ISCHEMIC MYOCARDIUM IN PERFUSED RAT-HEART [J].
HANEDA, T ;
ICHIHARA, K ;
ONODERA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (01) :81-87
[7]   EFFICACY OF LONG-TERM TREATMENT WITH NIPRADILOL, A NITROESTER-CONTAINING BETA-BLOCKER, IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION [J].
HANEDA, T ;
OGAWA, Y ;
AKAISHI, T ;
TAKEDA, H ;
TANAZAWA, S ;
INOUE, H ;
OHKI, Y ;
KATO, J ;
MORIMOTO, H ;
KANAYA, K ;
ONODERA, S ;
KIKUCHI, K .
CLINICAL THERAPEUTICS, 1995, 17 (04) :667-679
[8]   The beta adrenoreceptor antagonist, nipradilol preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit [J].
Hayashi, T ;
Yamada, K ;
Esaki, T ;
Muto, E ;
Iguchi, A .
LIFE SCIENCES, 1997, 61 (14) :1379-1387
[9]   Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia:: the possible role of peroxynitrite (ONOO-) [J].
Hayashi, T ;
Yamada, K ;
Esaki, T ;
Kano, H ;
Asai, Y ;
Thakur, NK ;
Jayachandran, M ;
Sumi, D ;
Iguchi, A .
ATHEROSCLEROSIS, 1999, 147 (02) :349-363
[10]   Nipradilol:: A β-adrenoceptor antagonist with nitric oxide-releasing action [J].
Hayashi, T ;
Iguchi, A .
CARDIOVASCULAR DRUG REVIEWS, 1998, 16 (03) :212-235